Taxol, a microtubule stabilizer, prevents atrial fibrillation in in vitro atrial fibrillation models using rabbit hearts

Medical Science Monitor

Volumn 16, Issue 11, 2010, Pages 353-360

  Xiao, Junjie ^a,b   Zhang, Hong ^b   Liang, Dandan ^b   Liu, Ying ^a,b   Liu, Yi ^b   Zhao, Hong ^b   Li, Jun ^b   Peng, Luying ^b   Chen, Yi Han ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Oxidative stress; Reactive oxygen species; Taxol

Indexed keywords

MULTIENZYME COMPLEX; PACLITAXEL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; CARDIOTONIC AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TUBULIN MODULATOR; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; FLUOROMETRY; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MALE; MICROTUBULE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; RABBIT; SPECTROPHOTOMETRY; TREATMENT OUTCOME; ANIMAL; DRUG EFFECT; HEART ATRIUM; HEART MUSCLE CELL; MECHANICAL STRESS; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; ANTIOXIDANT ACTIVITY; CHOLINERGIC SYSTEM; ENZYME ANALYSIS; ISOLATED HEART;

ANIMALS; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; CHOLINERGIC AGENTS; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX III; HEART ATRIA; MALE; MICROTUBULES; MODELS, ANIMAL; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; PACLITAXEL; RABBITS; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; STRESS, MECHANICAL; SUPEROXIDE DISMUTASE; TUBULIN MODULATORS; XANTHINE OXIDASE;

EID: 79951569769     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kim YH, Lim DS, Lee JH et al: Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med, 2003; 35: 336-49.
2. Banach M, Kazmierski J, Kowman M et al: Atrial fibrillation as a nonpsychiatric predictor of delirium after cardiac surgery: a pilot study. Med Sci Monit, 2008; 14(5): CR286-91.
3. Naji F, Suran D, Kanic V et al: Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion. Med Sci Monit, 2009; 15(9): CR494-98.
4. Nattel S: Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? Cardiovasc Res, 2002; 54: 347-60.
5. Dorian P, Singh BN: Upstream therapies to prevent atrial fibrillation. Eur Heart J Suppl, 2008; 10: H11-31.
6. Vest JA, Wehrens XH, Reiken sinus rhythm et al: Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation, 2005; 111: 2025-32.
7. Ravipati G, Aronow WS, Kumbar S et al: Patients with diabetes mellitus with ischemic stroke have a higher hemoglobin A1c level and a higher serum low-density lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci, 2009; 5: 391-93.
8. Benussi S, Galanti A, Alfieri O: Restoring sinus rhythm in patients at a high risk for postoperative atrial fibrillation. Arch Med Sci, 2008; 4: 108-15.
9. Małek MS, Zieliński T, Rywik T et al: The influence of cardiac rhythm type and frequency on the prognosis of severe heart failure patients initially qualified for heart transplantation. Ann Transplant, 2010; 15: 25-31.
10. Behjati M, Hashemi M: New-onset paroxysmal atrial fibrillation associated with smoked opium. Am J Case Rep, 2009; 10: CR198-200.
11. Behjati M, Hashemi M: Atrial fibrillation with rapid ventricular response in a case with piperazine citrate intoxication: A rare manifestation. Am J Case Rep, 2009; 10: CR201-4.
12. Bukowska A, Schild L, Keilhoff G et al: Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med, 2008; 233: 558-74.
13. Kim YM, Kattach H, Ratnatunga C et al: Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol, 2008; 51: 68-74.
14. Mihm MJ, Yu F, Carnes CA et al: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation, 2001; 104: 174-80.
15. Adam O, Frost G, Custodis F et al: Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol, 2007; 50: 359-67.
16. Dudley SC Jr, Hoch NE, McCann LA et al: Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation, 2005; 112: 1266-73.
17. Gerdes JM, Katsanis N: Small molecule intervention in microtubule-associated human disease. Hum Mol Genet, 2005; 14: R291-300.
18. Bloom K: Microtubule composition: Cryptography of dynamic polymers. Proc Natl Acad Sci USA, 2004; 101: 6839-40.
19. Nakamura Y, Miura T, Nakano A et al: Role of microtubules in ischemic preconditioning against myocardial infarction. Cardiovasc Res, 2004; 64: 322-30.
20. Ismaeil MS, Tkachenko I, Hickey RF, Cason BA: Colchicine inhibits isoflurane-induced preconditioning. Anesthesiology, 1999; 91: 1816-22.
21. Lampidis TJ, Kolonias D, Savaraj N, Rubin RW: Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents. Proc Natl Acad Sci USA, 1992; 89: 1256-60.
22. Parker KK, Taylor LK, Atkinson JB et al: The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias. Eur J Pharmacol, 2001; 417: 131-40.
23. Lee CF, Liu CY, Hsieh RH, Wei YH: Oxidative stress-induced depolymerization of microtubules and alteration of mitochondrial mass in human cells. Ann NY Acad Sci, 2005; 1042: 246-54.
24. Skobel E, Kammermeier H: Relation between enzyme release and irreversible cell injury of the heart under the influence of cytoskeleton modulating agents. Biochim Biophys Acta, 1997; 1362: 128-34.
25. Li J, Xiao JJ, Liang DD et al: Inhibition of mitochondrial translocator protein prevents atrial fibrillation. Eur J Pharmacol, 2010; 632: 60-64.
26. Xiao JJ, Liang DD, Zhang H et al: 4'-chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during post-ischemia reperfusion in rat in vitro. Exp Biol Med, 2010; 235: 478-86.
27. Li J, Xiao J, Liu Y et al: Mitochondrial benzodiazepine receptors mediate cardioprotection of estrogen against ischemic ventricular fibrillation. Pharmacol Res, 2009; 60: 61-67.
28. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest, 2005; 115: 500-8.
29. Neuman RB, Bloom HL, Shukrullah I et al: Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem, 2007; 53: 1652-57.
30. Carnes CA, Chung MK, Nakayama T et al: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res, 2001; 89: E32-38.
31. Kim YM, Guzik TJ, Zhang YH et al: A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res, 2005; 97: 629-36.
32. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation, 2003; 108: 1912-16.
33. Wachtell K, Lehto M, Gerdts E et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol, 2005; 45: 712-19.
34. Patti G, Chello M, Candura D et al: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation, 2006; 114: 1455-61.
35. Halonen J, Halonen P, Jarvinen O et al: Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. Jama, 2007; 297: 1562-67.
36. Kevin LG, Novalija E, Stowe DF et al: Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg, 2005; 101: 1275-87.
37. Huang GC, Liu SY, Lin MH et al: The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma. Jpn J Clin Oncol, 2004; 34: 499-504.
38. Teng M, Dang YM, Zhang JP et al: Microtubular stability affects cardiomyocyte glycolysis by HIF-1alpha expression and endonuclear aggregation during early stages of hypoxia. Am J Physiol Heart Circ Physiol, 2010; 298: H1919-31.
39. Xiao JJ, Cao HM, Liang DD et al: Taxol, a microtubule stabilizer, prevents ischemic ventricular arrhythmias in rats. J Cell Mol Med, 2010; DOI: 10.1111 /j.1582-4934.2010.01106.x.
40. Wang YF, Chen CY, Chung SF et al: Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol, 2004; 54: 322-30.
41. Devillard L, Vandroux D, Tissier C et al: Tubulin ligands suggest a microtubule- NADPH oxidase relationship in postischemic cardiomyocytes. Eur J Pharmacol, 2006; 548: 64-73.